/주식/GLOB
GLOB

GLOB

USD

Globant S.A. Common Shares

$62.815+0.795 (1.282%)

실시간 가격

기술
Information Technology Services
룩셈부르크

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$62.020

고가

$62.880

저가

$60.675

거래량

1.00M

기업 기본 정보

시가총액

2.8B

산업

Information Technology Services

국가

Luxembourg

거래 통계

평균 거래량

1.58M

거래소

NYQ

통화

USD

52주 범위

저가 $54.36현재가 $62.815고가 $238.32

관련 뉴스

PR Newswire

Globant to Announce Third Quarter 2025 Financial Results on November 13th

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will...

더 보기
Globant to Announce Third Quarter 2025 Financial Results on November 13th
PR Newswire

Globant to Announce Third Quarter 2025 Financial Results on November 13th

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will...

더 보기
Globant to Announce Third Quarter 2025 Financial Results on November 13th
Analyst Upgrades

Citigroup Initiates Coverage On Globant with Neutral Rating, Announces Price Target of $67

Citigroup analyst Bryan Keane initiates coverage on Globant with a Neutral rating and announces Price Target of $67.

더 보기
Citigroup Initiates Coverage On Globant with Neutral Rating, Announces Price Target of $67
Analyst Upgrades

Wells Fargo Initiates Coverage On Globant with Equal-Weight Rating, Announces Price Target of $61

Wells Fargo analyst Jason Kupferberg initiates coverage on Globant with a Equal-Weight rating and announces Price Target of $61.

더 보기
Wells Fargo Initiates Coverage On Globant with Equal-Weight Rating, Announces Price Target of $61
PR Newswire

MIT Technology Review Insights and Globant Report: Three quarters of global pharma organizations are piloting or deploying agentic AI

Globant (NYSE: GLOB), a digitally native company that helps organizations thrive in a digital and AI-powered future, has partnered with MIT...

더 보기
MIT Technology Review Insights and Globant Report: Three quarters of global pharma organizations are piloting or deploying agentic AI